PCN Insights, News, Videos, and More
Psychedelics Update
11/09/2026
Maria Mantas
Compass Pathways has completed submission of a New Drug Application for COMP360, an investigational synthetic psilocybin formulation for adults with treatment-resistant depression.
Compass Pathways has completed submission of a New Drug Application for COMP360, an investigational synthetic psilocybin formulation for adults with treatment-resistant depression.
Compass Pathways has completed...
11/09/2026
Psych Congress Network
Research Summary
11/09/2026
Brionna Mendoza
Psilocybin administration was associated with reductions in markers of systemic inflammation and mitochondrial stress among people with PD and mood dysfunction, according to a research letter published in JAMA Psychiatry.
Psilocybin administration was associated with reductions in markers of systemic inflammation and mitochondrial stress among people with PD and mood dysfunction, according to a research letter published in JAMA Psychiatry.
Psilocybin administration was...
11/09/2026
Psych Congress Network
Research Summary
11/05/2026
Maria Mantas
A self-led digital intervention targeting repetitive negative thinking significantly reduced anxiety during pregnancy and after childbirth, according to recent findings.
A self-led digital intervention targeting repetitive negative thinking significantly reduced anxiety during pregnancy and after childbirth, according to recent findings.
A self-led digital intervention...
11/05/2026
Psych Congress Network
Videos
11/03/2026
Kristian Dambrino, DNP, PMHNP, MSN
Kristian Dambrino, DNP, PMHNP-BC, explores how tardive dyskinesia considerations may influence antipsychotic treatment decisions in clinical practice.
Kristian Dambrino, DNP, PMHNP-BC, explores how tardive dyskinesia considerations may influence antipsychotic treatment decisions in clinical practice.
Kristian Dambrino, DNP,...
11/03/2026
Psych Congress Network
Videos
11/03/2026
Kristian Dambrino, DNP, PMHNP, MSN
Kristian Dambrino, DNP, PMHNP-BC, explores how tardive dyskinesia considerations may influence antipsychotic treatment decisions in clinical practice.
Kristian Dambrino, DNP, PMHNP-BC, explores how tardive dyskinesia considerations may influence antipsychotic treatment decisions in clinical practice.
Kristian Dambrino, DNP,...
11/03/2026
Psych Congress Network
Research Summary
11/02/2026
Brionna Mendoza
A single administration of mebufotenin benzoate nasal spray produced rapid, sustained reductions in depressive symptoms among adults with TRD, according to a phase 2b trial published in JAMA.
A single administration of mebufotenin benzoate nasal spray produced rapid, sustained reductions in depressive symptoms among adults with TRD, according to a phase 2b trial published in JAMA.
A single administration of...
11/02/2026
Psych Congress Network